Similarly, another study found that the inhibition of the MEK/ERK and PI3K/AKT pathways reduce the total EZH2 and H3K27me3 levels, resulting in a reduced transformation to AML [29]. The gene discussed is MAP2K7; the disease is acute myeloid leukemia.